Meeting Report

Published in:
Volume 5 / Year 2016 / Issue 3

Demonstrating interchangeability and biosimilarity for US biosimilars

Author(s): GaBI Journal Editor
Page: 139

Abstract: The US Food and Drug Administration (FDA) outlines its approach to biosimilarity and interchangeability at the 2016 Generic Pharmaceutical Association Biosimilars Council Conference. Topics covered include the FDA definition… Read More »

First Turkish interactive workshop on regulation and approval of similar biotherapeutic products/biosimilars, 2–3 March 2016, Ankara, Turkey

Author(s): Professor Philip D Walson, MD, Robin Thorpe, PhD, FRCPath
Page: 134-8

Abstract: This paper discusses the findings and summary of items covered in the First Turkish interactive workshop on regulation and approval of similar biotherapeutic products/biosimilars, in which structure–function was highlighted… Read More »

Go Back Print